Furthermore, Lian X et al. proposed the FLAIR risk score model, consisting of ferritin, lactate dehydrogenase, anti-MDA5 antibody, high-resolution CT imaging score, and RP-ILD, to predict the prognosis in patients with CADM-ILD. Here, IFIH1 is linked to clinically amyopathic dermatomyositis.